Lexaria Bioscience Correlations
LEXXW Stock | USD 0.25 0.05 25.00% |
The current 90-days correlation between Lexaria Bioscience Corp and Lexaria Bioscience Corp is -0.11 (i.e., Good diversification). The correlation of Lexaria Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Lexaria Bioscience Correlation With Market
Good diversification
The correlation between Lexaria Bioscience Corp and DJI is -0.07 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lexaria Bioscience Corp and DJI in the same portfolio, assuming nothing else is changed.
Lexaria |
Moving together with Lexaria Stock
0.85 | ILMN | Illumina Downward Rally | PairCorr |
0.84 | INZY | Inozyme Pharma Earnings Call This Week | PairCorr |
0.77 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.72 | ADTX | Aditxt Inc | PairCorr |
0.63 | TCRX | Tscan Therapeutics | PairCorr |
0.82 | TERN | Terns Pharmaceuticals | PairCorr |
0.81 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.81 | CTMX | CytomX Therapeutics Earnings Call This Week | PairCorr |
0.71 | EMBC | Embecta Corp | PairCorr |
0.65 | ADUS | Addus HomeCare | PairCorr |
0.65 | TLKMF | Telkom Indonesia Tbk | PairCorr |
Moving against Lexaria Stock
0.83 | OPT | Opthea Upward Rally | PairCorr |
0.71 | FENC | Fennec Pharmaceuticals | PairCorr |
0.71 | LTRN | Lantern Pharma | PairCorr |
0.64 | PHGE | Biomx Inc | PairCorr |
0.57 | GANX | Gain Therapeutics | PairCorr |
0.49 | CUE | Cue Biopharma | PairCorr |
0.33 | PFE | Pfizer Inc | PairCorr |
0.53 | DBVT | DBV Technologies Earnings Call Tomorrow | PairCorr |
0.43 | CPRX | Catalyst Pharmaceuticals | PairCorr |
0.39 | ELV | Elevance Health Sell-off Trend | PairCorr |
0.89 | GPI | Group 1 Automotive | PairCorr |
0.88 | EC | Ecopetrol SA ADR | PairCorr |
0.87 | T | ATT Inc Aggressive Push | PairCorr |
0.79 | WPM | Wheaton Precious Metals Sell-off Trend | PairCorr |
Related Correlations Analysis
-0.67 | 0.43 | 0.58 | 0.64 | LEXX | ||
-0.67 | -0.62 | -0.48 | -0.44 | LIXTW | ||
0.43 | -0.62 | 0.3 | 0.09 | GOVXW | ||
0.58 | -0.48 | 0.3 | 0.35 | RVPHW | ||
0.64 | -0.44 | 0.09 | 0.35 | IMTXW | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Lexaria Stock performing well and Lexaria Bioscience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lexaria Bioscience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
LEXX | 3.69 | (0.43) | 0.00 | (0.70) | 0.00 | 7.24 | 30.60 | |||
LIXTW | 10.63 | 1.91 | 0.11 | (0.32) | 10.33 | 33.33 | 110.32 | |||
GOVXW | 11.47 | 0.21 | 0.00 | 0.00 | 12.72 | 40.00 | 96.13 | |||
RVPHW | 13.90 | 1.45 | 0.07 | 0.39 | 14.78 | 29.41 | 135.71 | |||
IMTXW | 13.99 | (3.73) | 0.00 | (4.77) | 0.00 | 31.58 | 120.58 |
Lexaria Bioscience Corporate Management
Christopher Bunka | Chairman CEO | Profile | |
Vanessa Carle | Head Legal | Profile | |
Philip Ainslie | Advisor Consultant | Profile | |
Nelson CPA | Chief Officer | Profile | |
MS MD | Chief Board | Profile | |
Richard Christopher | Chief Officer | Profile |